Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperuricemia

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hyperuricemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, ZG; Ding, DD; Wang, HY; Wang, W1
Wang, L; Zhang, XP; Zhou, YF1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperuricemia

ArticleYear
The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:2

    Topics: Acute Disease; Animals; Humans; Hyperuricemia; Inflammation Mediators; Kidney; Microcirculation; NF-kappa B; Pancreatitis; Phospholipases A2; Platelet Activating Factor; Trypsin; Tumor Necrosis Factor-alpha

2008

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperuricemia

ArticleYear
[Changes of platelet α-particle membrane protein, platelet activating factor and platelet parameters in patients with hyperuricemia].
    Zhongguo shi yan xue ye xue za zhi, 2012, Volume: 20, Issue:2

    Topics: Adult; Aged; Blood Platelets; Case-Control Studies; Female; Humans; Hyperuricemia; Male; Middle Aged; P-Selectin; Platelet Activating Factor; Platelet Count

2012